ARCHIVES

Six Compounds Carcinogenic, Risk to Humans, CH Subgroup Finds

This article is from The Cancer Letter archive.

Vol. 05 No. 05 | February 2, 1979

Download PDF Visit The Full Archive

Related Articles

Addition of Cobimetinib Boosts PFS in BRAF Mutation-Positive Patients in Phase III Trial

July 25, 2014

Senate Bill Matches 42.01 Billion Bush request For NCI, Sets Bypass Funding For Breast Cancer

September 18, 1992

Bristol-Myers Adds UCLA, Fox Chase To Grants Program

April 12, 1985

DCT Board Okays New Projects, Rejects Nutrition Research Proposal

October 27, 1978

Group Lobby To Add $200 Mil. To Cancer Budget

April 26, 1991

NSABP Trial Finds Raloxifene Equivalent To Tamoxifen For Cancer Risk Reduction

April 28, 2006